Plain-English translation of NCT05847348 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a new imaging scan called that helps doctors find prostate cancer that has come back after treatment. The scan uses a small injection of a radioactive tracer followed by a specialized imaging test (PET/CT or PET/MRI) to look for cancer cells anywhere in your body. Researchers want to see how well this scan works in Chinese patients whose PSA levels have risen after surgery or radiation therapy.
When prostate cancer comes back after treatment, doctors need reliable ways to find where the cancer is located so they can plan the next steps. This medication may help doctors spot cancer more accurately than standard tests, which could lead to better treatment decisions.
If you join this study, you will receive an intravenous injection of the medication, which takes about 3–5 minutes. Then you'll wait 50–100 minutes before undergoing an imaging scan (either PET/CT or PET/MRI) that lasts about an hour; you'll lie on your back with your arms raised while the machine scans from your thighs to the top of your head. The study takes place at one of several hospitals in China, and you should plan to follow birth control precautions for 28 days after the injection.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
China